TMDX
TransMedics Group, Inc.
TransMedics Group, Inc. insider trading
Insiders at TransMedics Group, Inc. have been buying its stock on the open market. The largest purchase in the last 30 days was Weill David (Director) buying $109.1K of TMDX, filed Sep 14, 2026. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.
- Bought on the open market
- $109.1K
- Sold
- —
- Insiders
- 1
- Latest trade
- Sep 11, 2026
From SEC filings · last 30 days
Recent TMDX insider transactions
Weill DavidDirector
Bought 1,336 sh at $81.63 · Sep 11, 2026
$109.1K
Filing
SEC Form 4 data, Q3 2024 to Q2 2026
TMDX insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 10 insiders traded TMDX on the open market: 4 purchases worth $3M and 92 sales worth $29.5M, 72 of the sales pre-scheduled under a 10b5-1 plan. In the last four quarters alone: 4 purchases ($3M) and 13 sales ($5.4M), by 8 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | — | −$722.4K1 sale | |
| Q1 2026 | — | −$2.4M7 sales | |
| Q4 2025 | +$1M1 buy | −$1.8M4 sales · 1 on a plan | |
| Q3 2025 | +$2M3 buys | −$520K1 sale · all on a plan | |
| Q2 2025 | — | −$1.5M4 sales · 2 on a plan | |
| Q1 2025 | — | −$270.7K2 sales · 1 on a plan | |
| Q4 2024 | — | −$2.5M18 sales · all on a plan | |
| Q3 2024 | — | −$19.8M55 sales · 49 on a plan |
- Largest purchase
- +$1M of TMDX by Hassanein Waleed H (President & CEO · Director) on Nov 17, 2025.
- Largest sale
- −$4.4M of TMDX by Hassanein Waleed H (President & CEO · Director) on Aug 22, 2024.
Open-market transactions through Jun 30, 2026most recent first
Gunderson Thomas J.
Director
−$722.4K
Jun 15, 2026
9,624 sh · $75.06
Hernandez Gerardo
Chief Financial Officer
−$870.3K
Mar 04, 2026
5,912 sh · $147.21
Weill David
Director
−$524.3K
Mar 04, 2026
3,571 sh · $146.82
Hernandez Gerardo
Chief Financial Officer
−$194.9K
Mar 04, 2026
1,324 sh · $147.21
Lovell Stephanie
Director
−$178.5K
Mar 04, 2026
1,193 sh · $149.62
Corcoran Nicholas
See remarks
−$412.6K
Mar 02, 2026
2,966 sh · $139.12
Ranganath Anil P.
See remarks
−$120.2K
Mar 02, 2026
864 sh · $139.12
Hernandez Gerardo
Chief Financial Officer
−$52.2K
Mar 02, 2026
375 sh · $139.12
Hernandez Gerardo
Chief Financial Officer
−$128.5K
Dec 04, 2025
920 sh · $139.62
Weill David
Director
−$693.2K
Dec 03, 2025
5,000 sh · $138.64
Ranganath Anil P.
See remarks
−$435.7K
Nov 25, 2025
3,000 sh · $145.22
Hassanein Waleed H
President & CEO · Director
+$1M
Nov 17, 2025
8,775 sh · $114.00
Basile Edward M10b5-1
Director
−$540.3K
Oct 29, 2025
4,142 sh · $130.45
Hassanein Waleed H
President & CEO · Director
+$768.1K
Aug 07, 2025
6,617 sh · $116.08
Hassanein Waleed H
President & CEO · Director
+$217.1K
Aug 07, 2025
1,858 sh · $116.85
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Gunderson Thomas J.Director | 9,624 | $75.06 | −$722.4K |
| Mar 04, 2026 | Hernandez GerardoChief Financial Officer | 5,912 | $147.21 | −$870.3K |
| Mar 04, 2026 | Weill DavidDirector | 3,571 | $146.82 | −$524.3K |
| Mar 04, 2026 | Hernandez GerardoChief Financial Officer | 1,324 | $147.21 | −$194.9K |
| Mar 04, 2026 | Lovell StephanieDirector | 1,193 | $149.62 | −$178.5K |
| Mar 02, 2026 | Corcoran NicholasSee remarks | 2,966 | $139.12 | −$412.6K |
| Mar 02, 2026 | Ranganath Anil P.See remarks | 864 | $139.12 | −$120.2K |
| Mar 02, 2026 | Hernandez GerardoChief Financial Officer | 375 | $139.12 | −$52.2K |
| Dec 04, 2025 | Hernandez GerardoChief Financial Officer | 920 | $139.62 | −$128.5K |
| Dec 03, 2025 | Weill DavidDirector | 5,000 | $138.64 | −$693.2K |
| Nov 25, 2025 | Ranganath Anil P.See remarks | 3,000 | $145.22 | −$435.7K |
| Nov 17, 2025 | Hassanein Waleed HPresident & CEO · Director | 8,775 | $114.00 | +$1M |
| Oct 29, 2025 | Basile Edward M10b5-1Director | 4,142 | $130.45 | −$540.3K |
| Aug 07, 2025 | Hassanein Waleed HPresident & CEO · Director | 6,617 | $116.08 | +$768.1K |
| Aug 07, 2025 | Hassanein Waleed HPresident & CEO · Director | 1,858 | $116.85 | +$217.1K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Don't check TMDX — let it ping you
Watch every insider filing the minute it clears the SEC
The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.
TransMedics Group, Inc. is outside the ~660 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.
Other companies insiders are buying now
Questions
- Are TMDX insiders buying or selling?
- Between Sep 11, 2026 and Sep 11, 2026, 1 TransMedics Group, Inc. insider made 1 open-market purchase worth $109.1K and no sales, a net purchase of $109.1K.
- How much TMDX stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 10 TransMedics Group, Inc. insiders made 4 open-market purchases worth $3M and 92 sales worth $29.5M. 72 of the sales were pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: 4 purchases ($3M) and 13 sales ($5.4M). The largest purchase was Hassanein Waleed H buying $1M on Nov 17, 2025. The largest sale was Hassanein Waleed H selling $4.4M on Aug 22, 2024.
- What was the largest recent TMDX insider trade?
- Weill David (Director) bought $109.1K of TMDX stock on Sep 11, 2026 at about $81.63 a share.
- When did an insider last buy TMDX shares?
- The most recent open-market purchase on file is Weill David (Director) buying $109.1K on Sep 11, 2026.
- Where does TMDX insider trading data come from?
- From the Form 4 filings TransMedics Group, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
The week's real signals — open-market insider buys, cluster formations and what insiders did in TMDX and across the market — in plain English, with grants and routine vesting stripped out. Free, and honest about what the data can and cannot say.